share_log

Anebulo Pharmaceuticals Q2 EPS $(0.11) Misses $(0.10) Estimate

Moomoo 24/7 ·  Feb 13 16:43

Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.10) by 10 percent. This is a 26.67 percent increase over losses of $(0.15) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment